Infinitopes Precision Immunomics™
Vaccines · Health Care
Venture roundlatest round · Sep 2026 · 1 mo ago
4backers · Amplify Partners, Kindred Capital
$3.7Mgrants · 2 grants · CORDIS
10+team · employees, estimated range
Key facts
These are the key facts about Infinitopes Precision Immunomics™ on Alion as of Nov 13, 2026. Infinitopes Precision Immunomics™ is headquartered in Oxford, United Kingdom. It was founded in 2018.
- Headquarters
- Oxford, United KingdomAlion company profile, updated Oct 8, 2026
- Founded
- 2018Alion company profile, updated Oct 8, 2026
- Employees
- 10+Alion company profile, an estimated range
- Visa sponsorship, United Kingdom
- A-ratedUK Home Office · checked Nov 12, 2026
Official records
Funding and backers
Latest round
Venture round
Sep 2026 · 1 mo ago
Team
11-50
employees, estimated range
Grants
$3.7M
2 grants · CORDIS
Backers
4
Amplify Partners, Kindred Capital
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 25
Raised a round Venture round
Jan 28
Raised a round Venture round
Dec 13, 2023
Raised a round Venture round
Dec 1, 2023
Won a grant $1.1M · CORDIS
Jun 15, 2023
Raised a round Venture round
Dec 20, 2022
Raised a round Venture round
Dec 1, 2022
Won a grant $2.5M · CORDIS
Sep 24, 2021
Incorporated INFINITOPES LIMITED · Companies House
2018
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2026 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Jan 2026 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Dec 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Dec 2023 | $1.1M | — | CORDIS |
| Venture round | Jun 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Dec 2022 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Dec 2022 | $2.5M | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | INFINITOPES LIMITED | Companies House |
| Registered | 24 Sep 2021 |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Innovators in natural vaccine technology. Explore rapidly engineered, scalable vaccine technologies at Hexamer Therapeutics.
Protecting Our Future. ReNewVax is a next-generation bacterial vaccine company developing the first universal vaccine targeting all ca.100…
404 Err….or The vaccines you're looking for don't exist. Yet….
CREATE Medicines is pioneering in vivo immune cell programming with RNA powered, LNP delivered CAR therapies – unlocking scalable…
Animal Vaccine Delivery in Just 30 Minutes. Experience the world's fastest vaccine delivery. Get a complete range of vaccines delivered…
GIVAX is developing a new class of vaccines to protect children from severe gastroenteritis caused by rotavirus and norovirus. Leveraging…
Visa sponsorship
A-rated
Sponsor licence
Skilled Worker
Visa route
0
Open roles in United Kingdom
In the register as Infinitopes Limited, Oxford, Oxfordshire
Other sponsors in the same field
GSK plc
Gates Foundation 
bit.bio
Alert me
UK Home Office · checked Nov 12, 2026 · Visa details by country
Financials
Total raised
$3.7M
Latest round
Venture - Series Unknown
Funding rounds
7
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Kindred CapitalVia a fund
MANTA RAY Venture CapitalVia a fund
Amplify PartnersVia a fund
Octopus VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Infinitopes' £12.8M seed to advance cancer vaccine, ITOP-1
Cancer vaccines specialist Infinitopes Precision Immunomics Ltd. announced the closing of a £12.8 million (US$16.1 million) seed round and outlined plans to start a phase I/IIa study of the lead program in the third quarter of this year.
Read more
Report
Infinitopes: Cancer Biotechnology Company Raises £12.8 Million
Infinitopes Precision Immunomics, an integrated cancer biotech integrating sophisticated platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, announced the completion of a £12.8 million
Read more
Report
Report
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics antigen discovery technologies to target five more cancers
/PRNewswire/ -- Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine...
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Oxford
United Kingdom
HQ
No items found.
10-50 est. staff
How to cite this page
Alion, "Infinitopes Precision Immunomics™: key facts", as of Nov 13, 2026. https://alion.io/company/infinitopes
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0